Which hedge funds own ANAB? ANAPTYSBIO INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
11 of the hedge funds tracked by WhaleCreep disclosed a position in ANAB (ANAPTYSBIO INC) in their Q2 2026 13F filings, worth $191.7m in total. The largest holder by portfolio weight is Greenhaven Road Capital at 7.5% of its book. 3 managers opened a new position this quarter: Greenhaven Road Capital, Irenic Capital Management, Ancora Advisors. 1 exited: Point72 Asset Management LP.
11tracked managers holding
3opened this quarter
1exited this quarter
Which hedge funds hold ANAB? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Greenhaven Road Capital | Q2 2026 | 7.5% | $11.5m | 171,059 | – | new |
| Irenic Capital Management | Q2 2026 | 0.3% | $4.8m | 70,447 | – | new |
| Woodline Partners | Q2 2026 | 0.1% | $48.4m | 717,014 | 108% | added |
| Millennium Management | Q2 2026 | 0.0% | $54.5m | 807,316 | 70% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $36.4m | 539,666 | -7% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $26.6m | 394,373 | 69% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $899.7k | 13,329 | 21% | added |
| Ancora Advisors | Q2 2026 | 0.0% | $337.5k | 5,000 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $1.4m | 20,019 | 303% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $3.9m | 58,300 | -36% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $3.0m | 43,822 | -36% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Point72 Asset Management LP | 0.1% | $3.1m |
How has hedge fund ownership of ANAB changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $191.7m |
| Q1 2026 | 9 | $103.3m |
| Q4 2025 | 4 | $122.5m |
| Q3 2025 | 4 | $88.9m |
| Q2 2025 | 4 | $72.1m |
| Q1 2025 | 4 | $65.2m |
| Q4 2024 | 3 | $9.1m |
| Q3 2024 | 6 | $31.1m |
| Q2 2024 | 3 | $10.6m |
| Q1 2024 | 3 | $33.2m |
| Q4 2023 | 6 | $52.8m |
| Q3 2023 | 5 | $39.9m |
| Q2 2023 | 4 | $52.1m |
| Q1 2023 | 4 | $48.5m |
| Q4 2022 | 2 | $85.9m |
| Q3 2022 | 2 | $92.8m |
Counts every tracked manager that disclosed ANAB in that quarter's filing, including managers that have since stopped filing.